ISIS 113715 Withdrawn Phase 2 Trials for Type 2 Diabetes Mellitus Treatment

Indications	Status	Purpose	Phase
DBCOND0029752 (Type 2 Diabetes Mellitus)	Withdrawn	Treatment	2

clinicaltrials.gov Identifier	Title	Drugs
NCT00327626	Safety, Tolerability, and Activity of ISIS 113715 in People With Type 2 Diabetes Mellitus Being Treated With Sulfonylurea	ISIS 113715 (DB05506)